InvestorsHub Logo
Followers 13
Posts 461
Boards Moderated 0
Alias Born 03/08/2017

Re: fl_exec post# 1472

Friday, 07/21/2017 6:07:20 AM

Friday, July 21, 2017 6:07:20 AM

Post# of 2001
Because royalties if Birinapant ever comes to market. Risky yes, and a long ways away. Im just letting my small number of shares sit forever at this point. (only 200 lol) BUt may buy a few thousand more because it doesnt cost much and in a few years we will see if we get any money from Medivir:

"
PAOLI, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”) and its wholly-owned subsidiary TetraLogic Research and Development Corporation (“TDRC”) today announced that they have completed the sale to Medivir AB (Nasdaq Stockholm:MVIR) (“Medivir”) of their SMAC mimetic program, including their clinical stage asset birinapant, and their topical HDAC inhibitor, remetinostat (SHAPE), to Medivir (the “Sale”) for a purchase price of (i) $12 million payable in cash at closing plus (ii) milestone payments of up to $153 million based on the development and commercialization of TetraLogic’s product candidates by Medivir subject to certain conditions and limitations described in the Asset Purchase Agreement for the Sale and (iii) additional earn-out payments based on annual net sales of birinapant, subject to certain conditions and limitations described in the Asset Purchase Agreement for the Sale as follows:

the Company will be entitled to 5% of annual net sales from $0 to $500,000,000;
the Company will be entitled to 7.5% of annual net sales from $500,000,000 to $1,000,000,000; and
the Company will be entitled to 10% of annual net sales above $1,000,000,000.

"